291 CMEinfo presents a definitive multimedia course 41ST ANNUAL INTENSIVE REVIEW OF INTERNAL MEDICINE 41st Annual Intensive Review of Internal Medicine Provided by: Brigham and Women’s Hospital The Department of Medicine Harvard Medical School Postgraduate Medical Education ______________________________________________________________________________ Date of Original Release: October 1, 2018 Termination Date: January 31, 2021 (Please note that AMA PRA Category 1 Credits™ will no longer be issued for the activity after this date) Estimated Time to Complete the Activity: 85 hours Media: This educational activity is in the form of an online video and MP4 and/or Audio MP3 PROGRAM DESCRIPTION The Intensive Review of Internal Medicine course is designed to enhance internal medicine knowledge by offering a comprehensive update in internal medicine and its subspecialties. It will consist of a case-based review of challenging clinical problems and review of literature to guide evidence-based practice. This course can also serve to prepare attendees for the ABIM Board Examinations (Certification/Recertification). LEARNING OBJECTIVES Upon completion of this activity, participants will be able to: • Apply current/recommended guidelines in clinical practice • Perform differential diagnosis of complex clinical presentations • Identify/integrate current therapeutic options for specific disorders, including end-of-life care • Review and interpret up-to-date literature relevant to clinical practice • Describe pathophysiology as it applies to management of clinical problems • Apply knowledge gained to the ABIM certification/recertification examinations ACGME Competencies: This course is designed to meet one or more of the following Accreditation Council for Graduate Medical Education competencies: • Patient Care and Procedural Skills • Medical Knowledge • Practice-Based Learning and Improvement TARGET AUDIENCE The target audience for the Intensive Review of Internal Medicine course is clinical and academic internists, pediatricians, and primary care physicians/trainees preparing for ABIM internal medicine certification/recertification examinations and/or seeking a comprehensive update in internal medicine and its subspecialties. 291 METHOD OF PARTICIPATION: Review audio/video program of conference sessions, complete the comprehensive activity evaluation and score 70% or greater on the required post-test to assess the knowledge gained from reviewing the program. • Go to www.myoakstone.com and log in using your user ID and password • Click on your program to take your exam ACCREDITATION The Harvard Medical School is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. AMA CREDIT DESIGNATION STATEMENT The Harvard Medical School designates this enduring material for a maximum of 85 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. RISK MANAGEMENT CREDIT This activity meets the criteria of the Massachusetts Board of Registration in Medicine for 2.75 credits of Risk Management Study. This includes: .75 Credits of Opioid Education and Pain Management Training .75 Credits of End-of-Life Care Studies Please check your individual state licensing board requirements before claiming these credits. ABIM MOC MEDICAL KNOWLEDGE MOC POINTS Successful completion of this CME activity enables the participant to earn up to 85 MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC points. On the course evaluation page please indicate “Yes” when asked if you would like to receive ABIM MOC points for your participation in this enduring activity. You will then be required to provide your ABIM ID # and your Date of Birth. Points earned will equal the amount of AMA PRA Category 1 CreditsTM claimed. HMS will upload the participant data, including the points earned, directly to the ABIM so that it will appear on the ABIM diplomates transcript. These points will not appear on your certificate provided at the end of this enduring activity. 291 DISCLOSURE POLICY Harvard Medical School (HMS) adheres to all ACCME Essential Areas, Standards, and Policies. It is HMS’s policy that those who have influenced the content of a CME activity (e.g. planners, faculty, authors, reviewers and others) disclose all relevant financial relationships with commercial entities so that HMS may identify and resolve any conflicts of interest prior to the activity. These disclosures will be provided in the activity materials along with disclosure of any commercial support received for the activity. Additionally, faculty members have been instructed to disclose any limitations of data and unlabeled or investigational uses of products during their presentations. Disclosure information for all individuals in control of the content of the activity is located on the disclosure statement in the PDF and printed syllabus. HARDWARE/SOFTWARE REQUIREMENTS: ONLINE STREAMING: Windows 7, 8, or 10 on PC and Mac OS X or above on Mac computers with the most current version web browser (Internet Explorer or Edge, Firefox, Safari, and Chrome) for each. MP4 video / MP3 Audio USB: Any computer workstation that has a standard USB-A port and MP4 software player such as VLC (http://www.videolan.org/). MP3 Data CDs: Computer CD-ROM drive with compatible software MP4 player such as VLC (http://www.videolan.org/). If you experience technical difficulties, you can contact our Customer Service hotline at 1-800-284-8433. Disclaimer: CME activities sponsored by Harvard Medical School are offered solely for educational purposes and do not constitute any form of certification of competency. Practitioners should always consult additional sources of information and exercise their best professional judgment before making clinical decisions of any kind. WARNING: The copyright proprietor has licensed the picture contained on this recording for private home use only and prohibits any other use, copying, reproduction, or performance in public, in whole or in part (Title 17 USC Section 501 506). CMEinfo is not responsible in any way for the accuracy, medical or legal content of this recording. You should be aware that substantive developments in the medical field covered by this recording may have occurred since the date of original release. © 2018 Ebix, Inc. DBA Oakstone Publishing. LLC. CMEinfo is a registered trademark of Oakstone Publishing, LLC. 291 ACTIVITY DISCLOSURE STATEMENT 41st Annual Intensive Review of Internal Medicine Course Number: 732046-1901 Date of Original Release: October 1, 2018 / Termination Date: January 31, 2021 The Harvard Medical School is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. The Harvard Medical School designates this enduring material for a maximum of 85 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. This activity meets the criteria of the Massachusetts Board of Registration in Medicine for 2.75 credits of Risk Management Study. This includes .75 Credits of Opioid Education and Pain Management Training and .75 Credits of End-of-Life Care Studies. Please check your individual state licensing board requirements before claiming these credits. Harvard Medical School has long held the standard that its continuing medical education courses be free of commercial bias. In accord with the disclosure policy of the Medical School as well as standards set forth by the Accreditation Council for Continuing Medical Education, course planners, speakers, and content reviewers have been asked to disclose any relevant relationship they, or their spouse or partner, have to companies producing, marketing, re-selling or distributing health care goods or services consumed by, or used on, patients. In addition, faculty have been asked to list any off-label uses of pharmaceuticals and/or devices for investigational or non-FDA approved purposes that they plan to discuss. Such disclosure is not intended to suggest or condone bias in any presentation, but is elicited to provide the course director and participants with information that might be of potential importance to their evaluation of a given presentation. The following planners, speakers, and content reviewers, on behalf of themselves and their spouse or partner, have reported financial relationships with an entity producing, marketing, re-selling, or distributing health care goods or services (relevant to the content of the activity) consumed by, or used on, patients: NAME COMPANY RELATIONSHIP Course Planners and Faculty: Ajay K. Singh, MBBS, FRCP (UK) GlaxoSmithKline Consultant MBA Course Faculty: Maureen Achebe, MD, MPH AMAG Pharmaceuticals Advisory Board Luitpold Pharmaceuticals Consultant Elizabeth M. Battinelli, MD PhD Sanofi Consultant Carolyn Bernstein, MD Palmer Chiropractic Grant Support Amgen Consultant Marc P. Bonaca, MD, MPH Amgen Grant Support, Consultant AstraZeneca Grant Support, Consultant Merck Grant Support, Consultant MedImmune Grant Support Pfizer Grant Support Aralez Consultant Bayer Consultant Janssen Consultant Sanofi Consultant Barry Brenner, MD Janssen Consultant Jean M. Connors, MD Bristol-Myers Squibb Consultant/Scientific Advisory Board Boehringer Ingelheim Scientific Advisory Board Dova Pharmaceuticals Consultant Pfizer Consultant Portola Scientific Advisory Board Unum Therapeutics Data Safety Monitoring Board Paul Dellaripa, MD Genentech Principal Investigator Bristol-Myers Squibb Principal Investigator Akshay Desai, MD, MPH Abbott/St. Jude Medical Consultant Amgen Consultant AstraZeneca Consultant Boehringer Ingelheim Consultant DalCor Pharmaceuticals Consultant Janssen Consultant Novartis Consultant, Research Grants Relypsa Consultant Joerg Ermann, MD Boehringer Ingelheim Research Grant, Consulting Pfizer Research Grant Eli Lilly Scientific Advisory Board Novartis Scientific Advisory Board Hilary J. Goldberg, MD Genentech Member of Clinical Coordinating Center for Industry-Sponsored Study Samuel Z. Goldhaber, MD Boehringer Ingelheim Research Support, Consultant Bristol-Myers Squibb Research Support, Consultant BTG EKOS Research Support Daiichi Research Support, Consultant Janssen Research Support, Consultant Thrombosis Research Institute Research Support Agile Consultant Bayer Consultant Portola Consultant Soleno Consultant Sarah Hammond, MD Merck Research Support Lauren Harshman, MD Bayer Advisor/Research to the Institution/Travel Exelixis Advisor Genentech Advisor/Research to the Institution Dendreon/Valient Advisor/Research to the Institution Pfizer Advisor/Research to the Institution Medivation/Astellas Advisor/Research to the Institution Kew Group Advisor Theragene Advisor Corvus Advisor Merck Advisor/Research to the Institution Bristol-Myers Squibb Research to the Institution Janssen Research to the Institution Sotio Research to the Institution Takeda Research to the Institution Sanofi Travel Novartis Advisor Craig Hersh, MD Boehringer Ingelheim Grant Novartis Grant 23andMe Consultant Elliot Israel, MD AstraZeneca Consultant Entrinsic Health Solutions Consultant GlaxoSmithKline Consultant Merck Consultant Novartis Consultant 4D Pharma Consultant Pneuma Respiratory Consultant Regeneron Consultant Sanofi Consultant Vorso Corp Consultant Genentech Clinical Research Trial (BWH) Novartis Clinical Research Trial (BWH) Sanofi Clinical Research Trial (BWH) David Jackman, MD AstraZeneca Consultant CVS Caremark Consultant More Health Consultant Ursula Kaiser, MD Novo Nordisk Consultant Scott Kinlay, MBBS, PhD Colorado Prevention Center Data Safety Monitoring Board Ann LaCasce, MD Bristol-Myers Squibb Consulting Seattle Genetics Consulting Ming V. Lin, MD Gilead Advisory Board James Maguire, MD Bayer Advisory Committee Jeffrey Meyerhardt, MD Chugai Pharmaceuticals Consultant Ignyta Consultant Samia Mora, MD Atherotech Diagnostics Research Grant to Institution Anju Nohria, MD Amgen Research Support Takeda Oncology Consultant Paul M. Ridker, MD AstraZeneca Research Support, Co-Inventor on Licensed Patents Novartis Research Support, Research Consultant Pfizer Research Support Kowa Research Support Amgen Research Support Siemens Co-Inventor on Licensed Patents Quintiles Research Consultant Corvida Research Consultant Inflazome Research Consultant Eisai Research Consultant Sanofi Research Consultant Janssen Research Consultant Susan Ritter, MD Pfizer Spouse – Employee Marc S. Sabatine, MD Amgen Research Grant Support, Consulting AstraZeneca Research Grant Support, Consulting Daiichi-Sankyo Research Grant Support Eisai Research Grant Support GlaxoSmithKline Research Grant Support Intarcia Research Grant Support, Consulting Janssen Research and Dev. Research Grant Support, Consulting Medicines Company Research Grant Support, Consulting MedImmune Research Grant Support, Consulting Merck Research Grant Support, Consulting Novartis Research Grant Support, Consulting Pfizer Research Grant Support Poxel Research Grant Support Takeda Research Grant Support Bristol-Myers Squibb Consulting CVS Caremark Consulting Dyrnamix Consulting Esperion Consulting Robert C. Stanton, MD Janssen Pharmaceuticals Consultant Usha Tedrow, MD Abbott Medical Honorarium/Faculty, Fellows’ Course Biosense Webster Honorarium/Faculty, Fellows’ Course Medtronic Honorarium/Faculty, Fellows’ Course Derrick Todd, MD Optum Consultant Alexander Turchin, MD Merck Consultant Monarch Medical Technologies Consultant Eli Lilly Research Support Brio Systems Consultant All other individuals including course directors, planners, reviewers, faculty, staff, etc., who are in a position to control the content of this educational activity have, on behalf of themselves and their spouse or partner, reported no financial relationships related to the content of this activity. 41st Annual Intensive Review of Internal Medicine Faculty List ____________________________________________________ COURSE DIRECTORS: Ajay K. Singh, MBBS, FRCP (UK), MBA Carolyn B. Becker, MD Senior Associate Dean for Postgraduate Associate Professor of Medicine, Medical Education, Harvard Medical School, Director, Master in Medical Sciences in Division of Endocrinology, Clinical Investigation (MMSCI) Program Diabetes and Hypertension, Harvard Medical School, Department of Medicine, Director, Office of Postgraduate Brigham and Women’s Hospital Medical Education, Joseph Loscalzo, MD, PhD Brigham and Women’s Hospital Hersey Professor of the Theory and Nancy Berliner, MD Practice of Medicine, Professor of Medicine, Harvard Medical School, Harvard Medical School, Division of Cardiovascular Medicine, Chief, Division of Hematology, Chairman, Department of Medicine, Department of Medicine, Brigham and Women's Hospital Brigham and Women's Hospital FACULTY: Maureen M. Achebe, MD, MBBS Lindsey R. Baden, MD Assistant Professor of Medicine, Associate Professor of Medicine, Harvard Medical School, Harvard Medical School, Division of Hematology, Division of Infectious Diseases, Department of Medicine, Department of Medicine, Brigham and Women's Hospital Brigham and Women’s Hospital Dale S. Adler, MD Rebecca M. Baron, MD Associate Professor of Medicine, Assistant Professor of Medicine, Harvard Medical School, Harvard Medical School, Division of Cardiovascular Medicine, Division of Pulmonary and Critical Care Department of Medicine, Medicine, Department of Medicine, Brigham and Women’s Hospital Brigham and Women’s Hospital Edwin P. Alyea, III, MD Elisabeth M. Battinelli, MD Associate Professor of Medicine, Assistant Professor of Medicine, Harvard Medical School, Harvard Medical School, Medical Oncology, Division of Hematology, Dana-Farber Cancer Institute, Department of Medicine, Department of Medicine, Brigham and Women's Hospital Brigham and Women’s Hospital ____________________________________________________ David D. Berg, MD Wendy Y. Chen, MD, MPH Clinical Fellow in Medicine, Assistant Professor of Medicine, Harvard Medical School, Harvard Medical School, Chief Medical Resident, Medical Oncology, Department of Medicine, Dana-Farber Cancer Institute, Brigham and Women’s Hospital Department of Medicine, Brigham and Women’s Hospital Carolyn A. Bernstein, MD Assistant Professor of Neurology, Cheryl R. Clark, MD Harvard Medical School, Assistant Professor of Medicine, Department of Neurology, Harvard Medical School, Brigham and Women's Hospital Director, Health Equity Research & Intervention Marc P. Bonaca, MD Center for Community Health and Assistant Professor of Medicine, Health Equity, Harvard Medical School, Division of General Internal Medicine Division of Cardiovascular Medicine, and Primary Care, Department of Medicine, Department of Medicine, Brigham and Women’s Hospital Brigham and Women’s Hospital Kari P. Braaten, MD, MPH Nathan T. Connell, MD, MPH Instructor in Obstetrics, Assistant Professor of Medicine, Gynecology and Reproductive Biology, Harvard Medical School, Harvard Medical School, Division of Hematology, Department of Obstetrics and Gynecology, Department of Medicine, Brigham and Women's Hospital Brigham and Women's Hospital Barry M. Brenner, MD Jean M. Connors, MD Samuel A. Levine Distinguished Assistant Professor of Medicine, Professor of Medicine, Harvard Medical School, Harvard Medical School, Division of Hematology, Renal Division, Department of Medicine, Department of Medicine, Brigham and Women's Hospital Brigham and Women’s Hospital Julie E. Buring, ScD Paul F. Dellaripa, MD Professor of Medicine, Associate Professor of Medicine, Harvard Medical School, Harvard Medical School, Department of Medicine, Division of Rheumatology, Brigham and Women's Hospital Immunology and Allergy, Department of Medicine, Walter W. Chan, MD, MPH Brigham and Women’s Hospital Assistant Professor of Medicine, Harvard Medical School, Bradley M. Denker, MD Division of Gastroenterology, Associate Professor of Medicine, Hepatology and Endoscopy, Harvard Medical School, Department of Medicine, Renal Division, Brigham and Women's Hospital Department of Medicine, Beth Israel Deaconess Medical Center
Description: